Navigation Links
ActivBiotics Sells Proprietary Assets, Including Drug Product Candidates
Date:12/18/2007

LEXINGTON, Mass., Dec. 18 /PRNewswire/ -- ActivBiotics, Inc. today announced that following a review of strategic options after its clinical trial of Rifalazil failed in peripheral arterial disease patients, the Company is selling all or substantially all of its assets on an "as is" basis through an Assignment for the Benefit of Creditors, process. The Assignee of the assets is Mr. Joseph Finn, Jr., CPA (see contact details below). The bidding for the assets, which may be purchased separately or in combination, will begin today and end on February 1, 2008. Any person interested in purchasing the assets or learning more about the bidding process should contact the Assignee, Mr. Joseph Finn, Jr.

"The Board of Directors has decided to pursue the sale of the company's clinical and preclinical drug assets," said Steven C. Gilman, Ph.D., Chairman of ActivBiotics. "We believe that our anti-inflammatory Phase II drug candidate and our antibacterial library of compounds are of significant value to companies in those therapeutic areas," added Gilman. Bidding packages have been assembled and are ready to be distributed subject to a potential purchaser entering into a standard form confidentiality agreement.

The Company assets available for sale include:

1. A superoxide dismutase (SOD) mimetic program consisting of two clinical-stage drug candidates, M40403 and M40419, and a library of 250 small molecules which have potential as novel therapeutic agents for the treatment of inflammatory diseases. M40403, which has been studied in approximately 700 patients/subjects, has an active IND, and a protocol on file with the FDA under which a Phase II clinical trial for the treatment of post-operative ileus can be conducted, and a protocol to initiate a Phase II clinical trial for the treatment of oral mucositis. The Company has submitted and expects to shortly receive Orphan Drug Designation status in Europe and has an Orphan Drug application pending with th
'/>"/>

SOURCE ActivBiotics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Discas, Inc. Sells Shares to SNX Organic Fertilizers, Inc.
2. Exelixis Sells 80% Stake in Artemis to Taconic
3. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
4. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
5. Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)
6. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
7. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
8. AMDLs Jade Pharmaceutical Subsidiary Announces New Product Strategy; Six New Products, Including One With Sales Projected at Upwards of $10 Million, Under Development
9. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
10. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
11. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
Breaking Biology News(10 mins):Einstein receives high-risk/high-reward cancer research funding 2Einstein receives high-risk/high-reward cancer research funding 3Munich lab demonstrates diesel truck engine with barely measurable emissions 2Munich lab demonstrates diesel truck engine with barely measurable emissions 3Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 1Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 2Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 3Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 4Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 5Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 6Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 7Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 8Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 9Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 10Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 11Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 12Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 13Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 14Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 15Reportlinker Adds High Tech Patient Monitoring Systems Markets 28Remote and Wireless Systems Data Processing EMR Data Transfer 29 Report 14210 1Reportlinker Adds High Tech Patient Monitoring Systems Markets 28Remote and Wireless Systems Data Processing EMR Data Transfer 29 Report 14210 2Reportlinker Adds High Tech Patient Monitoring Systems Markets 28Remote and Wireless Systems Data Processing EMR Data Transfer 29 Report 14210 3Reportlinker Adds High Tech Patient Monitoring Systems Markets 28Remote and Wireless Systems Data Processing EMR Data Transfer 29 Report 14210 4Reportlinker Adds High Tech Patient Monitoring Systems Markets 28Remote and Wireless Systems Data Processing EMR Data Transfer 29 Report 14210 5Reportlinker Adds High Tech Patient Monitoring Systems Markets 28Remote and Wireless Systems Data Processing EMR Data Transfer 29 Report 14210 6Reportlinker Adds High Tech Patient Monitoring Systems Markets 28Remote and Wireless Systems Data Processing EMR Data Transfer 29 Report 14210 7Reportlinker Adds High Tech Patient Monitoring Systems Markets 28Remote and Wireless Systems Data Processing EMR Data Transfer 29 Report 14210 8Reportlinker Adds High Tech Patient Monitoring Systems Markets 28Remote and Wireless Systems Data Processing EMR Data Transfer 29 Report 14210 9Reportlinker Adds High Tech Patient Monitoring Systems Markets 28Remote and Wireless Systems Data Processing EMR Data Transfer 29 Report 14210 10SC Johnson a Best Company for Working Moms 57985 1SC Johnson a Best Company for Working Moms 57985 2SC Johnson a Best Company for Working Moms 57985 3